Related Experiment Videos
CLINICAL EXPERIENCE WITH A NEW DIURETIC, TRIAMTERENE, IN CONJESTIVE HEART FAILURE
Canadian Medical Association Journal
|August 15, 1964
Summary
Triamterene effectively manages chronic edema in heart failure patients, acting as a potent diuretic and natriuretic while conserving potassium. This study found no significant side effects during long-term therapy.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Congestive heart failure (CHF) often involves fluid overload and electrolyte imbalances.
- Diuretic therapy is crucial for managing edema in CHF patients.
- Potassium-sparing diuretics offer advantages in long-term management.
Purpose of the Study:
- To evaluate the efficacy and safety of triamterene in patients with congestive heart failure.
- To assess triamterene's effects on electrolyte balance and urine output.
- To determine triamterene's utility in long-term edema management.
Main Methods:
- Clinical assessment of 35 CHF patients over 2.5 years.
- Monitoring of daily urine electrolytes (sodium, potassium, chloride) and volume.
- Bi-weekly serum electrolyte analysis, uric acid, SGOT, hemogram, and BUN.
Main Results:
- Triamterene demonstrated moderate diuretic and natriuretic effects.
- Significant potassium conservation was observed.
- Synergistic effects with spironolactone and mitigation of hydrochlorothiazide's kaluretic effect were noted.
- No significant undesirable side effects were reported.
Conclusions:
- Triamterene is a valuable therapeutic option for long-term management of chronic edema in CHF.
- It is particularly useful in patients with arrhythmias linked to digitalis or hypokalemia.
- Triamterene can be used alone or in combination with other diuretics, especially in refractory cases.